Middle East Nuclear Imaging Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
The rise in the prevalence of cancer and cardiac ailments is one of the primary drivers for the market growth. Nuclear medicine is hugely capable in treating cancer and cardiac diseases. Cancer burden is increasing, owing to factors such as aging population, poor diet, smoking, and physical inactivity. According to Health Department of Abu Dhabi, in 2018, there were around 4,500 new cases of cancer each year in United Arab Emirates (UAE). Cancer incidence in the Middle East region is on the rise with the number of cases expected to double by 2030, according to the World Health Organisation (WHO). Cardiology applications are likely to continue to demonstrate significant growth in the market. In the field of cardiology, nuclear medicine imaging plays a crucial role in the diagnosis and management of patients having coronary artery disease (CAD), atherosclerosis, and other cardiovascular diseases. Nuclear medicine plays an important role in the diagnosis and management of patients with several diseases, which is a key growth factor for the market studied.
Key Market TrendsTechnetium-99m Segment is Expected to Show Better Growth in the Forecast YearsBased on SPECT radioisotopes, the market is segmented into Technetium-99m, Thallium-201, Gallium-67, Iodine-123, and Others. Technetium 99m is considered as the most widely used isotope in several diagnostic procedures. It is used in SPECT imaging, cardiac ventriculography, brain imaging, bone scans, and 3D scanning techniques.
Competitive LandscapeThe global players into the Middle East nuclear imaging market are Bracco Imaging SpA, Cardinal Health Inc., Curium, GE Healthcare, Koninklijke Philips N.V, NTP Radioisotopes SOC Ltd, Siemens AG and Toshiba Corporation.
Additional Benefits:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook